Retatrutide
Triple-Receptor Agonist Research Peptide
Retatrutide — 10 mg / vial
$189.00 $142.00 Launch Pricing
Launch Pricing text is populated automatically by js/layout.js.
Buy More & Save
- 1–2 vials$142.00 / vial
- 3–5 vials$134.90 / vial · 5% off
- 6–11 vials$127.80 / vial · 10% off
- 12+ vials$120.70 / vial · 15% off
Shipping text is populated automatically by js/layout.js.
Overview
Retatrutide is a synthetic peptide engineered to act on multiple metabolic hormone receptors simultaneously. The material Cinder Labs supplies is manufactured strictly for laboratory research use. Retatrutide itself is an actively studied investigational compound, with published research spanning in-vitro receptor characterization, rodent models, and human clinical trials conducted by its originating pharmaceutical sponsor.
Mechanism of Action (Research Context)
Research has investigated Retatrutide as a triple-receptor agonist, studied for its activity at receptors associated with glucose and energy-metabolism signaling pathways. Published human trials (cited below) have evaluated Retatrutide's effects on body weight and glycemic markers. Regardless of what has been published about the molecule elsewhere, the Retatrutide supplied by Cinder Labs is sold strictly for in-vitro and laboratory research use and is not intended for human or veterinary administration in any form.
Published Research
The studies below are real, publicly available research on retatrutide, linked here for further reading and education. They are cited for research-context reference only — Cinder Labs does not endorse, guarantee, or make any therapeutic claim based on their findings, and does not sell retatrutide for human or veterinary use.
Phase 2 Human Trial — Obesity
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial" — PubMed
Randomized, placebo-controlled human trial evaluating retatrutide's effect on body weight in adults with obesity.
Phase 2 Human Trial — Type 2 Diabetes
Randomized, controlled human trial evaluating retatrutide's effect on glycemic control and body weight in adults with type 2 diabetes.
Review — Mechanism & Development
Review summarizing retatrutide's receptor-binding mechanism and its clinical development to date.
Storage & Handling
Store lyophilized peptide in a freezer (-20°C or below) prior to reconstitution. Once reconstituted for laboratory use, store refrigerated (2–8°C) and use within the timeframe recommended by your laboratory's standard operating procedures. Avoid repeated freeze-thaw cycles. Handle only in a controlled laboratory environment using appropriate personal protective equipment.